Additionally, an experimental research indicated that obesity has the capacity to promote T cell malfunction and elevate the amount of PD‐1 positive T cells within the peripheral blood and tumors [21]; hence, this might partly explain the favorable impact of obesity on the effectiveness of ICIs. The gene discussed is PDCD1; the disease is obesity disorder.